Delineation of a 1 Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH

Genes Chromosomes and Cancer

Volumn 46, Issue 6, 2007, Pages 607-615

  Natrajan, Rachael ^a   Williams, Richard D ^a   Grigoriadis, Anita ^b   Mackay, Alan ^c   Fenwick, Kerry ^c   Ashworth, Alan ^c   Dome, Jeffrey S ^d   Grundy, Paul E ^e   Pritchard Jones, Kathy ^a   Jones, Chris ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SPACER DNA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER DIAGNOSIS; CANCER GENETICS; CANCER SCREENING; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DCLRE1B GENE; DNA MICROARRAY; DNA SEQUENCE; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTRON; KARYOTYPE; MICROARRAY ANALYSIS; NEPHROBLASTOMA; NONHUMAN; ONCOGENE N RAS; PHTF1 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRIM33 GENE; TUMOR SUPPRESSOR GENE; CHROMOSOME 1; EVALUATION; GENE DOSAGE; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENETICS; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE REPEAT; STANDARD;

CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 1; GENE DOSAGE; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSLOCATION, GENETIC; WILMS TUMOR;

EID: 34247516817     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20446     Document Type: Article

References (24)

1. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. 2003. Translocation and gross deletion breakpoints in human inherited disease and cancer. I. Nucleotide composition and recombination-associated motifs. Hum Mutat 22:229-244.
2. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365-371.
3. Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, deJong PJ, Zhao S, Liebman M, Weber BL. 2004. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 14:179-187.
4. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM. 2005. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the national Wilms tumor study group. J Clin Oncol 23:7312-7321.
5. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J. 2006. Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFB pathway. Cell 125:929-941.
6. Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K. 2001. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 158:393-398.
7. Hoglund M, Gisselsson D, Hansen GB, Mitelman F. 2004. Wilms tumors develop through two distinct karyotypic pathways. Cancer Genet Cytogenet 150:9-15.
8. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. 2004. Analysis of array CGH data: From signal ratio to gain and loss of DNA regions. Bioinformaties 20:3413-3422.
9. Jin Y, Jin C, Wennerberg J, Mertens F, Hoglund M. 1998. Cytogenetic and fluorescence in situ hybridization characterization of chromosome 1 rearrangements in head and neck carcinomas delineate a target region for deletions within 1p11-1p13. Cancer Res 58:5859-5865.
10. Kleinjan DJ, van Heyningen V. 1998. Position effect in human genetic disease. Hum Mol Genet 7:1611-1618.
11. Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ, Gilson E. 2006. The Apollo 5′ exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr Biol 16:1303-1310.
12. Manuel A, Beaupain D, Romeo PH, Raich N. 2000. Molecular characterization of a novel gene family (PHTF) conserved from Drosophila to mammals. Genomics 64:216-220.
13. Natrajan R, Williams RD, Hing SN, Mackay A, Reis-Filho JS, Fenwick K, Iravani M, Valgeirsson H, Grigoriadis A, Langford CF, Dovey O, Gregory SG, Weber BL, Ashworth A, Grundy PE, Pritchard-Jones K, Jones C. 2006. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol 210:49-58.
14. Nuwaysir EF, Huang W, Albert TJ, Singh J, Nuwaysir K, Pitas A, Richmond T, Gorski T, Berg JP, Ballin J, McCormick M, Norton J, Pollock T, Sumwalt T, Butcher L, Porter D, Molla M, Hall C, Blattner F, Sussman MR, Wallace RL, Cerrina F, Green RD. 2002. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 12:1749-1755.
15. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557-572.
16. Paris PL, Andava A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. 2004. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 13:1303-1313.
17. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME. 2006. Global variation in copy number in the human genome. Nature 444:444-454.
18. Reiter A, Saussele S, Grimwade D, Wiemels JL, Segal MR, Lafage-Pochitaloff M, Walz C, Weisser A, Hochhaus A, Willer A, Reichert A, Buchner T, Lengfelder E, Hehlmann R, Cross NC. 2003. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia. Genes Chromosomes Cancer 36:175-188.
19. Sawyer JR, Thomas EL, Lukacs JL, Swanson CM, Ding Y, Parham DM, Thomas JR, Nicholas RW, 2002. Recurring breakpoints of 1p13 approximately p22 in osteochondroma. Cancer Genet Cytogenet 138:102-106.
20. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, Nair P, Brothman AR, Stallings RL. 2005. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44:305-319.
21. Singh-Gasson S, Green RD, Yue Y, Nelson C, Blattner F, Sussman MR, Cerrina F. 1999. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat Biotechnol 17:974-978.
22. Smedley D, Sidhar S, Birdsall S, Bennett D, Herlyn M, Cooper C, Shipley J. 2000. Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 28:121-125.
23. Waber PG, Chen J, Nisen PD. 1993. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors. Cancer 72:3732-3738.
24. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, Knudsen S. 2002. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3:research0048.